Recent Developments in Targeting the Cell Cycle in Melanoma is a research paper published in Cancers (2025). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: R21CA277480
NIH
Grant: R01 CA285713
NIH
Grant: R01 CA240362
NIH
Grant: R01 CA238229
National Institutes of Health
Grant: 5R01CA238229-03
Allosteric inhibitors targeting oncogenic BRAF V600E dimers
National Institutes of Health
Grant: 5R01CA240362-02
REGULATION AND ADAPTIVE MECHANISMS OF ONCOGENIC RAS/ERK SIGNALING
National Institutes of Health
Grant: 1R01CA285713-01
Mechanisms determining tumor-selective potency of RAS pathway inhibitors
National Institutes of Health
Grant: 1R21CA277480-01
TERT epigenetic and genomic variants in stage II melanoma as biomarkers of outcome
Fields of Study
Keywords